第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
By Phase
Phase II-III Clinical
Strategy, Planning, Execution. Your end-to-end partner with phase II-III development experience in dozens of countries.
Accelerating Your Clinical Trial with a Comprehensive Suite of Services
Large scale clinical trial means increasingly complex study designs, evermore challenging subject enrollment, and demand for therapeutic knowledge, every project is different and “one size does not fit all”.
We provide science-driven strategy, customized planning, and seasoned project management team with relevant scientific and therapeutic expertise in your specific study needs.
Leveraging our robust in-house quality management system, well-developed SOPs, extensive experience in international project management, and dedicated regulatory submission team, we can accelerate your clinical trial and deliver the right data so your therapies can reach patients faster.
Why Tigermed for Clinical Trials
Specialized Operation Team
Diversified Customers & Partners
Customized Strategy & Solutions
Key Service Capabilities for Phase II-III Clinical Development
一体化II-III期临床研究服务能力
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
第三方稽查
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.